SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Acquisition

17 Feb 2022 07:00

RNS Number : 9338B
CLS Holdings PLC
17 February 2022
 

 

Release date: 17 February 2022

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS" or the "Group")

announces the €25 million acquisition of an office building in Dusseldorf

 

CLS announces that is has unconditionally exchanged contracts to acquire a 9,168 sqm / 98,684 sq. ft office building in Dusseldorf for €25 million (€2,724 per sqm) excluding costs from alstria office REIT-AG.

 

Kanzlerstraße 8 is situated in a well-connected and growing submarket in Dusseldorf. The overground station, Dusseldorf Rath, and the underground station, Rather Waldstadion, are both within 400m of the asset. The airport can be reached within 10 minutes by car and the central station in 16 minutes by overground. Dusseldorf is one of the main political, economic, and cultural centre of the Rhine-Ruhr region with a population of c. 11 million and one of the "Top 7" office markets.

 

The property is currently occupied by three tenants including the anchor tenant Amevida (c. 70% by space), Kinderparadies, and ConSol with a WAULT of c. 8 years. CLS plans to let remaining vacant space, enhance the carpark and ESG credentials, and manage the future lease breaks. The property currently has a net initial yield of 5.1% and a reversionary yield of 5.7%.

 

The acquisition is expected to complete in April 2022.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"This asset is a well-located office building and benefits from an existing strong tenant base with the opportunity to secure market rents and valuation uplifts in the years ahead. This acquisition also reflects our confidence in the underlying strength of the German office market, particularly in key regional cities. We look forward to working with the tenants to improve the building further and enhancing its sustainability."

 

-ends-

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFZGMZZVZGZZZ
Date   Source Headline
11th Apr 20254:09 pmRNSDirector/PDMR Shareholding
8th Apr 20253:43 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:48 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAnnual Financial Report
27th Mar 20257:00 amRNSSale of Spring Mews Student
19th Mar 20257:31 amRNSDirector Declaration
13th Mar 20255:02 pmRNSDirector/PDMR Shareholding
26th Feb 20255:53 pmRNSTrading Update Correction
24th Feb 20257:00 amRNSTrading Update 24 February 2025
11th Feb 20253:13 pmRNSDirector/PDMR Shareholding
6th Feb 20257:00 amRNSUpdated redevelopment plans for Spring Gardens
14th Jan 20255:26 pmRNSTransfer of Treasury Shares to EBT and TVR
10th Jan 20254:33 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSCLS leases 29,816 sf for 10 years at Fetter Lane
19th Dec 20247:00 amRNSCLS leases 9,600 sqm to the City of Dortmund
11th Dec 202412:46 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTrading Update 12 November 2024
12th Nov 20245:21 pmRNSDirector/PDMR Shareholding
11th Oct 20241:51 pmRNSDirector/PDMR Shareholding
11th Sep 20244:19 pmRNSDirector/PDMR Shareholding
6th Sep 20241:51 pmRNSChange of Auditor
4th Sep 20247:00 amRNSCLS leases over 8,900 sqm in Hamburg, Germany
12th Aug 20243:24 pmRNSDirector/PDMR Shareholding
7th Aug 20247:01 amRNSCLS Holdings Half Year Report
7th Aug 20247:00 amRNSCLS leases 12,052 sqft at Artesian, Prescot Street
1st Aug 20247:00 amRNSNotice of Half Year Results
11th Jul 202411:24 amRNSDirector/PDMR Shareholding
28th Jun 20244:58 pmRNSDirector Declaration
24th Jun 20247:00 amRNSCLS development plans for Citadel Place, Vauxhall
17th Jun 20247:00 amRNSCLS announces conversion of Debussy, Paris
14th Jun 20245:32 pmRNSDirector/PDMR Shareholding
10th Jun 20247:00 amRNSCLS updates on further sales progress
17th May 202412:52 pmRNSDirector Declaration
9th May 202411:18 amRNSDirector/PDMR Shareholding
9th May 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:33 pmRNSResult of AGM
15th Apr 20247:00 amRNSCLS Announces the Sale of Westminster Tower
11th Apr 20244:34 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSCLS Investor Presentation: Investor Meet Company
22nd Mar 20245:31 pmRNSAnnual Financial Report
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSAnnual Financial Report
28th Feb 202412:00 pmRNSNotice of Results
7th Feb 20245:37 pmRNSDirector/PDMR Shareholding
9th Jan 20245:27 pmRNSDirector/PDMR Shareholding
8th Dec 20235:40 pmRNSDirector/PDMR Shareholding
21st Nov 20234:57 pmRNSDirector/PDMR Shareholding
21st Nov 202311:13 amRNSDirector Declaration
15th Nov 20237:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.